查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553442

紐約合法大麻市場規模、佔有率和趨勢分析：按來源、衍生物、種植、最終用途和細分市場預測（2024-2030）

New York Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC, Others), By Cultivation (Indoor Cultivation, Greenhouse Cultivation), By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

紐約合法大麻市場成長與趨勢

Grand View Research, Inc.最新報告顯示，預計2030年紐約合法大麻市場規模將達32.2億美元，2024年至2030年複合年成長率為15.3%。藥用大麻合法化、消費者可支配收入增加、消費者對大麻健康益處的認知提高、製藥業對大麻的需求增加以及美國農業法案的核准等因素預計將推動市場成長。

成年人使用大麻來治療各種疾病，包括心理健康問題、癌症、噁心和疼痛。在預測期內，癌症盛行率的不斷上升預計將極大促進醫用大麻的接受度不斷提高。例如，根據紐約政府公佈的資料，每年有116,000名紐約人被診斷出罹患癌症。

大眾對大麻治療角色的認知不斷提高，大麻認證教育和培訓計畫數量不斷增加，正在推動市場成長。例如，旅行培訓計劃是紐約州大麻勞動力計劃的一部分。這是康乃爾大學工業與勞動關係學院和非營利勞動發展研究所之間的合作項目，部分資金來自國家。該計劃已成功對數百人進行了大麻產業基本方面的教育。

此外，與大麻相關的研究活動的增加正在推動市場成長。 2023年8月，大麻研究許可證法規實施。該法規允許獲得許可的研究人員測試大麻的成分水平和化學效力，研究大麻作為醫療的安全性和有效性，進行農業和基因組研究，並對可種植、加工的大麻衍生藥物進行臨床研究。和擁有用於執行等目的。

紐約合法大麻市場報告亮點

  • 從來源來看，由於對醫用大麻的研究和研究不斷增加，大麻細分市場在 2023 年佔據了最大的收益佔有率。
  • 從衍生性商品來看，由於注入 CBD 的藥品、食品和化妝品擴大被採用，CBD 細分市場在 2023 年佔據了最大的收益佔有率。
  • 從種植來看，由於有利的政府法規和大麻種植者數量的增加，2023年室內種植領域佔據了最大的收益佔有率。
  • 以最終用途分類，由於越來越多的消費者以吸煙和電子煙的形式消費大麻，娛樂用途細分市場在 2023 年佔據了最大的市場佔有率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章紐約合法大麻市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 案例研究分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析
  • 監管狀況

第4章紐約合法大麻市場細分分析：依來源分類（2018-2030）

  • 定義和範圍
  • 源細分儀表板
  • 2018-2030年市場規模、預測及趨勢分析
  • 麻
    • 市場估計與預測（2018-2030）
    • 油
    • 工業大麻
  • 大麻
    • 市場估計與預測（2018-2030）
    • 花
    • 油和酊劑

第5章紐約合法大麻市場細分分析：依衍生性商品分類（2018-2030）

  • 定義和範圍
  • 衍生性細分儀表板
  • 2018-2030年市場規模、預測及趨勢分析
  • CBD
    • 市場估計與預測（2018-2030）
  • THC
    • 市場估計與預測（2018-2030）
  • 其他
    • 市場估計與預測（2018-2030）

第6章 紐約合法大麻市場細分分析：依種植情況分類（2018-2030）

  • 定義和範圍
  • 種植細分儀表板
  • 2018-2030年市場規模、預測及趨勢分析
  • 室內栽培
    • 市場估計與預測（2018-2030）
  • 溫室栽培
    • 市場估計與預測（2018-2030）
  • 戶外栽培
    • 市場估計與預測（2018-2030）

第7章 紐約合法大麻市場細分分析：依最終用途分類（2018-2030）

  • 定義和範圍
  • 最終用途細分儀表板
  • 2018-2030年市場規模、預測及趨勢分析
  • 工業用途
    • 市場估計與預測（2018-2030）
  • 醫療用途
    • 市場估計與預測（2018-2030）
    • 慢性疼痛
    • 憂鬱症和焦慮
    • 關節炎
    • 創傷後壓力症候群（PTSD）
    • 癌症
    • 偏頭痛
    • 癲癇
    • 阿茲海默症
    • 多發性硬化症
    • 肌萎縮側索硬化症
    • 妥瑞症
    • 糖尿病
    • 帕金森氏症
    • 青光眼
    • 其他
  • 休閒用途
    • 市場估計與預測（2018-2030）

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 公司市場分析
  • 公司簡介
    • Curaleaf Holdings, Inc.
    • New York Hemp Oil
    • COOKIES CREATIVE PRODUCTIONS &CONSULTING, INC.
    • ACREAGE HOLDINGS.
    • Cannabist Company Holdings Inc.
    • Cresco Labs
    • PharmaCann Inc.
    • Canna West Seattle
    • Vireo Health International, Inc.
    • Green Thumb Industries（GTI）
Product Code: GVR-3-68038-420-8

New York Legal Cannabis Market Growth & Trends:

The New York legal cannabis market size is expected to reach USD 3.22 billion by 2030, registering a CAGR of 15.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the legalization of medicinal cannabis, rising consumer disposable income, increasing consumer awareness of the health benefits of cannabis, growing demand for cannabis from the pharmaceutical industry, and the approval of the U.S. Farm Bill are expected to boost market growth.

Cannabis is utilized for managing a range of ailments, including mental health issues, cancer, nausea, and pain, and for adult use purposes. The increasing prevalence of cancer is expected to significantly contribute to the increasing acceptance of medical marijuana over the forecast period. For instance, according to data published by the Government of New York, annually 116,000 New Yorkers are diagnosed with cancer.

The growing awareness among people regarding the therapeutic benefits of cannabis and the rise in cannabis certification educational and training programs fuel market growth. For instance, the travelling training program is a part of the New York State Cannabis Workforce Initiative. It's a collaboration between Cornell University's School of Industrial & Labor Relations and the non-profit Workforce Development Institute, which is partly funded by the state. This program has successfully educated hundreds of individuals in the fundamental aspects of the cannabis industry.

Moreover, the increase in research activities related to cannabis is driving the market growth. In August 2023, regulations for Cannabis Research Licenses were implemented. These regulations allow licensed researchers to cultivate, process, purchase, and possess cannabis for the purpose of testing its composition levels and chemical potency, studying the safety and effectiveness of cannabis as a medical treatment, conducting agricultural or genomic research, as well as carrying out clinical studies of cannabis-derived drug products.

New York Legal Cannabis Market Report Highlights:

  • Based on source, the marijuana segment accounted for the largest revenue share in 2023, owing to the growing research studies on cannabis for its medical use
  • Based on derivatives, the CBD segment dominated the market with the largest revenue share in 2023, owing to the growing adoption of CBD-infused medication, food, and cosmetics
  • Based on cultivation, the indoor cultivation segment accounted for the largest revenue share in 2023, owing to favorable government regulations and a rise in the number of cannabis cultivators
  • Based on end-use, the recreational use segment held the largest market share in 2023 due to the rise in the number of consumers adopting cannabis consumption in the form of smoking and vaping

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Source
    • 1.2.2. Derivatives
    • 1.2.3. Cultivation
    • 1.2.4. End-use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Source outlook
    • 2.2.2. Derivatives outlook
    • 2.2.3. Cultivation outlook
    • 2.2.4. End Use outlook
  • 2.3. Competitive Landscape Snapshot

Chapter 3. New York Legal Cannabis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Case Study Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Landscape

Chapter 4. New York Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Source Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4. Hemp
    • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Hemp Oil
      • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Industrial Hemp
      • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Marijuana
    • 4.5.1. Market estimates and forecasts, 2018 to 2030, (USD Million)
    • 4.5.2. Flower
      • 4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Oil and Tinctures
      • 4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. New York Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Derivatives Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4. CBD
    • 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. THC
    • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. New York Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Cultivation Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4. Indoor Cultivation
    • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Greenhouse Cultivation
    • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Outdoor Cultivation
    • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. New York Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 7.1. Definition and Scope
  • 7.2. End Use Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4. Industrial Use
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Medical Use
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. Chronic Pain
      • 7.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. Depression and Anxiety
      • 7.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. Arthritis
      • 7.5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. Post Traumatic Stress Disorder (PTSD)
      • 7.5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Cancer
      • 7.5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.7. Migraines
      • 7.5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.8. Epilepsy
      • 7.5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.9. Alzheimer's
      • 7.5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.10. Multiple Sclerosis
      • 7.5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.11. Amyotrophic Lateral Sclerosis
      • 7.5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.12. Tourette's
      • 7.5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.13. Diabetes
      • 7.5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.14. Parkinson's
      • 7.5.14.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.15. Glaucoma
      • 7.5.15.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.16. Others
      • 7.5.16.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Recreational Use
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Position Analysis
  • 8.4. Company Profiles
    • 8.4.1. Curaleaf Holdings, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Service Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. New York Hemp Oil
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Service Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. COOKIES CREATIVE PRODUCTIONS & CONSULTING, INC.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Service Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. ACREAGE HOLDINGS.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Service Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Cannabist Company Holdings Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Service Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Cresco Labs
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Service Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. PharmaCann Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Service Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Canna West Seattle
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Service Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Vireo Health International, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Service Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Green Thumb Industries (GTI)
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Service Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 New York legal cannabis market, by source, 2018 - 2030 (USD Million)
  • Table 4 New York legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
  • Table 5 New York legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
  • Table 6 New York legal cannabis market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Value-chain-based sizing & forecasting
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market research approaches
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. cannabis market: market outlook
  • Fig. 9 U.S. cannabis competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Industry value chain analysis
  • Fig. 13 New York legal cannabis market driver impact
  • Fig. 14 New York legal cannabis market restraint impact
  • Fig. 15 New York legal cannabis market strategic initiatives analysis
  • Fig. 16 New York legal cannabis market: Source movement analysis
  • Fig. 17 New York legal cannabis market: Source outlook and key takeaways
  • Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
  • Fig. 19 Hemp Oil market estimates and forecasts, 2018 - 2030
  • Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
  • Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
  • Fig. 22 Flower market estimates and forecasts, 2018 - 2030
  • Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
  • Fig. 24 New York legal cannabis market: Derivatives movement analysis
  • Fig. 25 New York legal cannabis market: Derivatives outlook and key takeaways
  • Fig. 26 CBD market estimates and forecasts, 2018 - 2030
  • Fig. 27 THC market estimates and forecasts, 2018 - 2030
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030
  • Fig. 29 New York legal cannabis market: Cultivation movement analysis
  • Fig. 30 New York legal cannabis market: Cultivation outlook and key takeaways
  • Fig. 31 Indoor Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 32 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 33 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 34 New York legal cannabis market: End Use movement analysis
  • Fig. 35 New York legal cannabis market: End Use outlook and key takeaways
  • Fig. 36 Industrial Use market estimates and forecasts, 2018 - 2030
  • Fig. 37 Medical Use market estimates and forecasts, 2018 - 2030
  • Fig. 38 Chronic Pain market estimates and forecasts, 2018 - 2030
  • Fig. 39 Depression and Anxiety market estimates and forecasts, 2018 - 2030
  • Fig. 40 Arthritis market estimates and forecasts, 2018 - 2030
  • Fig. 41 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
  • Fig. 42 Cancer market estimates and forecasts, 2018 - 2030
  • Fig. 43 Migraines market estimates and forecasts, 2018 - 2030
  • Fig. 44 Epilepsy market estimates and forecasts, 2018 - 2030
  • Fig. 45 Alzheimer's market estimates and forecasts, 2018 - 2030
  • Fig. 46 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
  • Fig. 47 AIDS market estimates and forecasts, 2018 - 2030
  • Fig. 48 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
  • Fig. 49 Tourette's market estimates and forecasts, 2018 - 2030
  • Fig. 50 Diabetes market estimates and forecasts, 2018 - 2030
  • Fig. 51 Parkinson's market estimates and forecasts, 2018 - 2030
  • Fig. 52 Glaucoma market estimates and forecasts, 2018 - 2030
  • Fig. 53 Others market estimates and forecasts, 2018 - 2030
  • Fig. 54 Recreational Use market estimates and forecasts, 2018 - 2030
  • Fig. 55 Key company categorization